5,823 Shares in Addus HomeCare Corporation $ADUS Purchased by Evolve Private Wealth LLC

Evolve Private Wealth LLC purchased a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,823 shares of the company’s stock, valued at approximately $585,000.

Several other hedge funds have also made changes to their positions in the stock. BlackRock Inc. bought a new stake in Addus HomeCare in the 2nd quarter valued at about $344,153,000. Capital Research Global Investors grew its position in Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares during the last quarter. Vanguard Group Inc. grew its position in Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after purchasing an additional 10,501 shares during the last quarter. Wasatch Advisors LP increased its stake in shares of Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after purchasing an additional 7,089 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Addus HomeCare by 11.8% in the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock valued at $69,689,000 after purchasing an additional 78,415 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

ADUS opened at $120.82 on Tuesday. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 21.20, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $124.43. The business has a 50 day moving average price of $109.99 and a two-hundred day moving average price of $102.58.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same period last year, the company posted $1.49 EPS. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Research analysts predict that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of analyst reports. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Royal Bank Of Canada raised their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Barclays upped their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average target price of $130.88.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.